Relationship of B‐type natriuretic peptide and anemia in patients with and without heart failure: A substudy from the Breathing Not Properly (BNP) Multinational Study
Open Access
- 24 October 2005
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 80 (3) , 174-180
- https://doi.org/10.1002/ajh.20456
Abstract
While anemia is a significant risk factor for poor outcomes in patients with heart failure (HF), it is not in defined guidelines for HF assessment. B‐type natriuretic peptide (BNP) is a marker for diagnosis and management of patients with HF. We determined the incidence of anemia in patients with HF and the relationship between BNP and hemoglobin (Hgb) levels in patients with and without HF. Results from the Breathing Not Properly Multinational Trial consisted of 1586 patients presenting to the emergency department (ED) with dyspnea. Because renal insufficiency is a confounding variable for BNP, patients with a creatinine of ≥2.0 mg/dL were excluded. The remaining data were evaluated from 620 non‐HF patients (337 M, 283 F) and 547 HF patients (299 M, 248 F). The New York Heart Association (NYHA) HF classification and ejection fraction by echocardiography were assessed for HF patients. Blood was tested for Hgb, BNP, and creatinine. Using World Health Organization criteria for anemia, we observed that HF patients in NYHA class III or IV had lower mean Hgb levels (12.5 g/dL, P < 0.05) and a higher incidence of anemia (48.2%, P < 0.05) than did HF patients in class I or II (13.4 g/dL and 33.9%, respectively). There was no correlation between Hgb and log BNP for females without HF or the aggregate of all HF patients. In contrast, a significant inverse correlation was observed for males without HF (P < 0.001). Although there were differences in the BMI, age, and estimated glomerular filtration rate (eGFR) versus Hgb observed in this group, the log BNP correlation remained significant after multivariate analysis. A significant inverse correlation for log BNP and Hgb were also observed for diastolic (EF ≥ 50) HF (P < 0.05) that was also not accounted for by the BMI, age, or eGFR. The presence of anemia is associated with worsening HF at ED presentation. For males without HF and diastolic HF patients of both genders, a low Hgb may be a confounding variable toward increasing BNP. Among systolic HF patients, the presence of a low hemoglobin concentration is not a factor in the interpretation of BNP results. Am. J. Hematol. 80:174–180, 2005.Keywords
This publication has 21 references indexed in Scilit:
- Effect of anemia on plasma concentrations of NT-proBNPClinica Chimica Acta; International Journal of Clinical Chemistry, 2005
- Anemia and Its Relationship to Clinical Outcome in Heart FailureCirculation, 2004
- Relation of anemia to diastolic heart failure and the effect on outcomeThe American Journal of Cardiology, 2004
- Impact of Obesity on Plasma Natriuretic Peptide LevelsCirculation, 2004
- Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18Journal of the American College of Cardiology, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNPHeart, 2000
- Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart DiseaseScandinavian Journal of Urology and Nephrology, 1996
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976